Reverse merger has long been considered as a shortcut to public listing. Previous researches cast doubts on the time and cost saving procedure. Negative public sentiment devalues Chinese RM firms by comparing them with long listed companies. To find a way out for Chinese emerging firms, I impartially analyse the listing rules of Chinese exchanges versus US exchanges, and explore the earnings potential of CRMs by examining their post-reverse acquisition performance. The result shows that CRMs exhibit no worse than their domestic counterparts and even better than those listed through IPO in the US.